Testing effectiveness (Phase 2)Ended earlyNCT01074359
What this trial is testing
Safety and Efficacy Study of A0001 in Patients With the A3243G Mitochondrial DNA Point Mutation
Who this might be right for
Neuromuscular Disease
Penwest Pharmaceuticals Co. 30